FTLF vs. ANNX, PHVS, KROS, MREO, RAPP, DNA, TRDA, TRML, ORKA, and XERS
Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Annexon (ANNX), Pharvaris (PHVS), Keros Therapeutics (KROS), Mereo BioPharma Group (MREO), Rapport Therapeutics (RAPP), Ginkgo Bioworks (DNA), Entrada Therapeutics (TRDA), Tourmaline Bio (TRML), Oruka Therapeutics (ORKA), and Xeris Biopharma (XERS). These companies are all part of the "pharmaceutical products" industry.
FitLife Brands vs.
Annexon (NASDAQ:ANNX) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
Annexon received 52 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 77.14% of users gave Annexon an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.
2.3% of FitLife Brands shares are held by institutional investors. 12.7% of Annexon shares are held by insiders. Comparatively, 61.3% of FitLife Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
FitLife Brands has a net margin of 13.38% compared to Annexon's net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Annexon's return on equity.
Annexon currently has a consensus target price of $15.80, suggesting a potential upside of 276.19%. FitLife Brands has a consensus target price of $40.00, suggesting a potential upside of 23.19%. Given Annexon's higher probable upside, equities research analysts plainly believe Annexon is more favorable than FitLife Brands.
In the previous week, Annexon had 2 more articles in the media than FitLife Brands. MarketBeat recorded 4 mentions for Annexon and 2 mentions for FitLife Brands. Annexon's average media sentiment score of 0.94 beat FitLife Brands' score of 0.36 indicating that Annexon is being referred to more favorably in the media.
Annexon has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.
FitLife Brands has higher revenue and earnings than Annexon. Annexon is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Summary
FitLife Brands beats Annexon on 10 of the 17 factors compared between the two stocks.
Get FitLife Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FitLife Brands Competitors List
Related Companies and Tools
This page (NASDAQ:FTLF) was last updated on 1/21/2025 by MarketBeat.com Staff
